N-adamantyl derivatives of aromatic amines. Part I. Synthesis and neurotropic activity of N-(adamant-2-yl)anilines-Reference-Cited by-同舟云学术

N-adamantyl derivatives of aromatic amines. Part I. Synthesis and neurotropic activity of N-(adamant-2-yl)anilines

Published:1998-01 Issue:1 Volume:32 Page:1-4
ISSN:0091-150X
Container-title:Pharmaceutical Chemistry Journal
language:en
Short-container-title:Pharm Chem J

Author:

Morozov I. S.,Klimova N. V.,Lavrova L. N.,Avdyunina N. I.,Pyatin B. M.,Troitskaya V. S.,Bykov N. P.

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/BF02464216.pdf

Reference11 articles.

1. R. S. Schwab, D. C. Poskanzer, A. C. England, et al.,J. Am. Med. Assoc.,222(7), 792–795 (1972).

2. S. K. Germane, M. M. Krima, D. A. Berzinya, and Ya. B. Briede,Targeted Search for New Neuroleptic Preparations [in Russian], Zinatne, Riga (1983), pp. 42–59.

3. T. W. Stone,Br. J. Pharmacol.,56, 101–110 (1976).

4. Yu. I. Vikhlyaev, T. A. Voronina, N. V. Klimova, et al.,Khim.-Farm. Zh.,14(3), 59–62 (1980).

5. Yu. I. Vikhlyaev, O. V. Ul'yanova, T. A. Voronina, et al.,Khim.-Farm. Zh.,14(5), 45–48 (1980).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Achievements in the Copper-Catalyzed Arylation of Adamantane-Containing Amines, Di- and Polyamines;Catalysts;2023-05-01

2. N,N-Di(prop-2-yn-1-yl)adamantan-1-amines in 1,3-Dipolar Cycloaddition Reactions with Azide-Containing Pharmacophores;Russian Journal of General Chemistry;2019-08

3. Host-guest complexes of 2-hydroxypropyl- β -cyclodextrin/ β -cyclodextrin and nifedipine: 1 H NMR, molecular modeling, and dissolution studies;Journal of Molecular Structure;2017-12

4. Reaction of adamantan-2-amine and (adamantan-1-yl)methylamine with methyl 2-(4-allyl-2-methoxyphenoxy)acetate;Russian Chemical Bulletin;2017-09

5. Potential Synthetic Adaptogens. II. Synthesis and Pharmacological Activity of New Conformationally Labile Bromantane Analogs, N-[(Adamantan-1-YL)Methyl]-4-Bromoanilines;Pharmaceutical Chemistry Journal;2017-03